Katrin Milger Selected Research

Asthma (Bronchial Asthma)

3/2024	Long-term multicenter comparison shows equivalent efficacy of monoclonal antibodies in severe asthma therapy.
3/2024	As-needed low-dose inhaled corticosteroid/formoterol therapy in patients with severe asthma included in the German Asthma Net cohort.
12/2023	Initiation, response assessment, and switch of antibody therapies in patients with severe asthma - A survey among German specialists.
12/2023	Biologics for severe asthma and beyond.
11/2023	Characterization of Obesity in Severe Asthma in the German Asthma Net.
8/2023	Criteria for evaluation of response to biologics in severe asthma - the Biologics Asthma Response Score (BARS).
6/2023	Impact of short-term pausing of oral corticosteroids on blood eosinophil count in patients with severe asthma.
4/2023	[Criteria for evaluation of response to biologics in severe asthma - the Biologics Asthma Response Score (BARS)].
1/2023	Real-World Experience on the Use of Mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study).
1/2023	Domestic Parasitic Infections in Patients with Asthma and Eosinophilia in Germany - Three Cases with Learnings in the Era of Anti- IL5 Treatments.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katrin Milger Research Topics

Disease

25	Asthma (Bronchial Asthma) 03/2024 - 01/2017
12	Pulmonary Hypertension 01/2023 - 10/2011
9	Pulmonary Arterial Hypertension 07/2023 - 09/2013
4	Inflammation (Inflammations) 12/2023 - 01/2017
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 12/2018
4	Lung Diseases (Lung Disease) 01/2023 - 01/2018
3	Eosinophilia 06/2023 - 12/2021
3	Infections 10/2021 - 11/2014
3	Disease Progression 10/2020 - 01/2016
2	Obesity 11/2023 - 12/2020
2	Hypertension (High Blood Pressure) 01/2023 - 12/2020
2	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 07/2021
2	Cytomegalovirus Infections (Inclusion Disease) 10/2021 - 01/2020
2	COVID-19 07/2021 - 01/2021
2	Idiopathic Pulmonary Fibrosis 01/2019 - 01/2016
2	Emphysema 01/2015 - 10/2011
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2024
1	Myocardial Infarction 04/2024
1	Obstructive Lung Diseases (Obstructive Lung Disease) 04/2024
1	Stroke (Strokes) 04/2024
1	Bronchiectasis 11/2023
1	Connective Tissue Diseases (Connective Tissue Disease) 07/2023
1	Virus Diseases (Viral Diseases) 01/2023
1	Upper Extremity Deep Vein Thrombosis 01/2023
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2023
1	Thrombosis (Thrombus) 01/2023
1	Parasitic Diseases (Parasitic Disease) 01/2023
1	Familial Primary Pulmonary Hypertension 10/2022
1	Heart Failure 02/2022
1	Bronchiolitis Obliterans Syndrome 01/2022
1	Neuromuscular Diseases (Neuromuscular Disease) 01/2022
1	Deglutition Disorders (Dysphagia) 01/2022
1	Airway Obstruction (Choking) 01/2022
1	Chronic Renal Insufficiency 12/2021
1	Nasal Polyps (Nasal Polyp) 07/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Coronary Disease (Coronary Heart Disease) 12/2020
1	Diabetes Mellitus 12/2020
1	Nausea 01/2020
1	Diarrhea 01/2020
1	Vomiting 01/2020
1	Status Asthmaticus 01/2019

Drug/Important Bio-Agent (IBA)

12	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2024 - 01/2020
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2024 - 06/2015
6	Monoclonal AntibodiesIBA 03/2024 - 01/2021
6	Biomarkers (Surrogate Marker)IBA 12/2023 - 12/2020
4	dupilumabIBA 03/2024 - 01/2020
4	benralizumabIBA 03/2024 - 01/2021
4	Interleukin-5 (Interleukin 5)IBA 01/2023 - 01/2020
3	mepolizumabIBA 03/2024 - 01/2021
3	Immunoglobulin E (IgE)IBA 11/2023 - 01/2021
3	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2020
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 01/2022
3	AntibodiesIBA 07/2021 - 01/2020
2	CytokinesIBA 01/2023 - 01/2022
2	SmokeIBA 01/2023 - 10/2011
2	Interleukin-5 Receptors (Interleukin 5 Receptor)IBA 12/2022 - 01/2021
2	Bronchodilator Agents (Bronchodilators)IBA 12/2022 - 12/2022
2	Carbon MonoxideIBA 10/2022 - 12/2020
2	letermovirIBA 10/2021 - 01/2020
2	RNA (Ribonucleic Acid)IBA 07/2021 - 01/2021
2	anti-IgE antibodiesIBA 01/2021 - 12/2018
2	Interleukin-13IBA 01/2020 - 01/2017
2	pirfenidoneIBA 01/2019 - 01/2016
2	Sildenafil Citrate (Viagra)FDA Link 01/2016 - 06/2015
1	BilirubinIBA 04/2024
1	Formoterol Fumarate (Oxis)FDA Link 03/2024
1	InterleukinsIBA 12/2023
1	Muscarinic AntagonistsIBA 11/2023
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 07/2023
1	Natriuretic PeptidesIBA 01/2023
1	Histocompatibility Antigens Class IIBA 01/2023
1	riociguatIBA 02/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022
1	Cytisus-type anti-H(O) lectins (CSA-I)IBA 01/2022
1	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 01/2022
1	pro-brain natriuretic peptide (1-76)IBA 01/2022
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022
1	Ganciclovir (Cytovene)FDA LinkGeneric 10/2021
1	AntigensIBA 01/2021
1	CotinineIBA 01/2020
1	Interleukin-4 (Interleukin 4)IBA 01/2020
1	regadenoson FDA Link 01/2020
1	SteroidsIBA 01/2020
1	Epoprostenol ReceptorsIBA 01/2019
1	Omalizumab (Xolair)FDA Link 01/2019

Therapy/Procedure

31	Therapeutics 03/2024 - 09/2013
5	Lung Transplantation 04/2024 - 01/2018
5	Biological Therapy 12/2023 - 12/2018
3	Artificial Respiration (Mechanical Ventilation) 01/2022 - 01/2019
1	Percutaneous Coronary Intervention 04/2024
1	Transplantation 04/2024
1	Central Venous Catheters 01/2023
1	Catheters 01/2023
1	Parenteral Nutrition 01/2023
1	Mechanical Ventilators (Ventilator) 01/2022
1	Tracheostomy 01/2022
1	Hematopoietic Stem Cell Transplantation 01/2020